The ingredient house FutureCeuticals has several products to its name, and you can find them all throughout the sports nutrition industry, from its performance powerhouse, elevATP, the pump-powering S7 blend, and the focus-enhancing CognatiQ. It is the nootropic that has FutureCeuticals in the news this week, as it is claiming an increasingly popular, competing ingredient infringes on the IP that’s gone into CognatiQ, originally known as NeuroFactor.
FutureCeuticals has officially filed a lawsuit against Aura Scientific, claiming its brain performance ingredient NeuroRush directly infringes multiple patents related to coffee fruit compositions. The company is seeking financial damages, a ruling of willful infringement, and the complete halt of NeuroRush sales. FutureCeuticals emphasizes its longstanding position as the creator of the whole coffee fruit segment, backed by its patents, research, and clinical trials.
In its statement, FutureCeuticals described Aura Scientific’s NeuroRush as adding nothing original, instead “piggybacking” on the quality work behind CognatiQ and NeuroFactor, and harming both the company and its licensees. The lawsuit intends to stop Aura Scientific and remove NeuroRush from the market. FutureCeuticals also suggests supplement brands using the ingredient reconsider in light of the situation and its intent to aggressively defend its IP.
